Erasca, Inc.

Erasca, Inc. is a clinical-stage precision oncology company dedicated to developing novel therapies that target the RAS/MAPK pathway, a key signaling cascade frequently mutated in cancer. They are driven by the mission to "erase cancer" and focus on developing treatments for patients with various solid tumors, including melanoma, colorectal cancer, and glioblastoma. Their research efforts center around identifying and developing small molecule inhibitors that selectively target oncogenic RAS alterations and block the activation of wildtype RAS isoforms, preventing tumor resistance.

Erasca is headquartered in San Diego, California, and has a second location in San Francisco. Their commitment to social responsibility is reflected in their establishment of the Erasca Foundation, which supports cancer research, patient advocacy, and other socially impactful initiatives. The company also prioritizes inclusive clinical trial participation and drug access programs, demonstrating their dedication to improving the lives of patients.

Erasca offers flexible work arrangements for several of their open positions. Their postings indicate that the Associate Director Safety Science, Director Clinical Operations, and Executive Director & Head, Biostatistics roles can be based in San Diego or South San Francisco with the option of working fully remotely anywhere in the United States. This suggests that Erasca values work-life balance and supports employees in choosing the work environment that best suits their needs.

Erasca offers a comprehensive and competitive benefits package to its employees including paid time off, holiday and sick leave, medical, dental and vision plans, short and long term disability, life insurance, flexible spending accounts, critical illness and accident coverage, pet insurance, an employee assistance program, a 401(k) plan with company contribution, and the opportunity to participate in an employee stock purchase program.

Erasca, Inc. is a clinical-stage precision oncology company dedicated to developing and commercializing innovative medicines that target the RAS/MAPK pathway, a critical signaling cascade implicated in various cancers affecting millions of people worldwide. The company's mission is to "erase cancer" by developing therapies that effectively shut down this pathway, ultimately aiming to improve the lives of patients battling these diseases.

Erasca fosters a collaborative and fast-paced environment driven by a shared mission to "erase cancer." Their culture emphasizes scientific excellence, innovation, and a commitment to patients, while valuing diversity and inclusion. The company encourages a team-based approach, emphasizing open communication and the ability to adapt quickly to changing needs. Erasca prioritizes a work-life balance, offering a comprehensive benefits package and opportunities for career growth within a supportive and engaging workplace.

Erasca prioritizes diversity, equity, and inclusion across its organization, striving to create a welcoming and inclusive environment for all employees. They actively seek to hire diverse talent and provide equal opportunities for growth and advancement regardless of race, religion, national origin, gender, sexual orientation, or any other protected status. Erasca demonstrates commitment to these values through its open and transparent recruitment practices, ongoing employee training programs, and a supportive culture that encourages individual contributions.